Human CD30 ligand antigen binding proteins
US9926373B2 · kind B2 · utility
2Cited by
7References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 25, 2013 |
| Grant date | Mar 27, 2018 |
| Priority date | — |
| Expiry date | Sep 15, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are compositions and methods relating to human CD30L antigen binding proteins. Compositions described herein include: human CD30L antigen binding proteins, polynucleotides encoding human CD30L antigen binding proteins, vectors comprising these polynucleotides, host cells, and pharmaceutical compositions. Methods of making and using each of these compositions are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.